Postmarketing clinical study on AO-128
Phase 4
- Conditions
- Impaired glucose tolerance
- Registration Number
- JPRN-jRCT1080220971
- Lead Sponsor
- Takeda Pharmaceutical Company Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 197
Inclusion Criteria
1.The subject is an out patient during screening
2.The subject signs a written informed consent form prior to the initiation of any study procedures.
And the others.
Exclusion Criteria
1.The subject with serious cardiac disease, cerebrovascular disorder, or any serious pancreatic or hematological disease, etc..
2.The subject who is considered ineligible to participate in the study by the investigator or subinvestigator.
And the others.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method